Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing surgery with or without internal radiation therapy versus stereotactic body radiation therapy for high-risk stage …
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients [Phase 3]
A Phase 3 CAPPA-2 trial evaluating cisplatin added to gemcitabine in poor-performance advanced non-small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing chemotherapy versus observation in patients with early-stage non-small cell lung cancer has terminated with result…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial update of atezolizumab in PD-L1 positive locally advanced or metastatic non-small cell lung cancer completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2017-03-21Clinical Trial Update: A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating Ginsenoside H Dripping Pills for advanced non-small cell lung cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-20Clinical Trial Update: A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection [Phase 3]
Phase III trial update for Recombinant Human Apo-2 Ligand for Injection in stage IV non-small cell lung cancer; the current trial status is …
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC [Phase 2]
Phase 2 trial comparing FLT-PET with FDG-PET/CT for early chemotherapy response assessment in resectable stage IB-IIIA non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: A Study of ARQ 197 in Combination With Erlotinib [Phase 1]
Phase 1 study evaluating ARQ 197 in combination with erlotinib in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: A Study of ARQ 197 in Combination With Erlotinib [Phase 1]
Phase 1 study evaluating ARQ 197 in combination with erlotinib for advanced or recurrent non-small-cell lung cancer. The trial status is com…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC [Phase 2]
This update covers a Phase 2 neoadjuvant trial of gefitinib (Iressa) in patients with Stage I non-small cell lung cancer. The study status i…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Computer-Generated Quality of Life Assessment Program for Advanced Non-Small Cell Lung Cancer Patients (LUNL2) [NA]
The trial NCT01337102 evaluated a computer-generated quality-of-life assessment program for patients with advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 study evaluating MetMAb in combination with Tarceva for MET-positive non-small cell lung cancer has completed, with the trial stat…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients [Phase 3]
Phase 3 trial comparing crizotinib to chemotherapy in previously untreated East Asian patients with ALK-positive non-small cell lung cancer;…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations [Phase 2]
Phase II open-label randomized study comparing AUY922 against pemetrexed or docetaxel in NSCLC patients with EGFR mutations; trial terminate…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Pilot Study of Regional Lung Ventilation [NA]
A pilot study evaluating regional lung ventilation in non-small cell lung cancer has completed, according to the clinical trials update.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating the safety, preliminary efficacy, and pharmacokinetics of CT-707 in patients with ALK-positive non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy
Expanded Access study of Alectinib for ALK-rearranged non-small cell lung cancer after progression on or intolerance to prior ALK inhibitors…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating a MEK inhibitor combined with a PI3K/mTOR inhibitor in subjects with locally advanced or metastatic solid tumors; r…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Phase 2 Trial of Bevacizumab in Combination With Pemetrexed [Phase 2]
This document reports the results of a Phase 2 trial evaluating bevacizumab in combination with pemetrexed for non-small cell lung cancer, w…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer [Phase 2]
This clinical trial update notes the termination of a Phase 2 study comparing Radiation Therapy versus Observation after chemotherapy in pat…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy [Phase 3]
Phase 3 trial comparing prophylactic cranial irradiation versus no PCI in non-small cell lung cancer patients after chemotherapy response; t…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of combining Imprime PGG with Bevacizumab and Paclitaxel/Carboplatin in adults with untreat…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers [Phase 1]
Phase 1 study assessing the combination of panobinostat with sorafenib in renal cell carcinoma, soft tissue sarcoma, and non-small cell lung…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: TAilored Post-Surgical Therapy in Early Stage NSCLC [Phase 2, Phase 3]
Phase 2/3 trial evaluating tailored post-surgical therapy for early-stage non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Chemotherapy and Erlotinib for Lung Cancer With Low Abundance Epidermal Growth Factor Receptor Mutation [Phase 2]
A Phase 2 trial investigating the combination of chemotherapy and erlotinib for non-small cell lung cancer with low-abundance EGFR mutations…